Skip to main content
REVIVA PHARMACEUTICALS HOLDINGS, INC. logo

REVIVA PHARMACEUTICALS HOLDINGS, INC. — Investor Relations & Filings

Ticker · RVPH ISIN · VGG8708A1167 US Professional, scientific and technical activities
Filings indexed 399 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

https://revivapharma.com/

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company that discovers and develops next-generation therapeutics for diseases with significant unmet medical needs. The company's primary focus is on central nervous system (CNS), respiratory, and metabolic diseases. Its lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms in Alzheimer's disease, Parkinson's disease psychosis, and attention deficit hyperactivity disorder (ADHD). Reviva utilizes a chemical genomics-driven technology platform to develop medicines with the goal of achieving better safety and efficacy profiles for improved patient outcomes.

Recent filings

Filing Released Lang Actions
10-Q - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Regulatory Filings
2026-05-13 English
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Regulatory Filings
2026-05-13 English
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Regulatory Filings
2026-04-15 English
S-8 - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Regulatory Filings
2026-03-30 English
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
Regulatory Filings
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.